Medtronic

Loading

Overview

Medtronic & Covidien Transaction Information


Information Resources for Investors on the Medtronic Announcement of its intent to acquire Covidien can be found:

Medtronic – Covidien Updated Financing Plans Fact Sheet 11-25-2014
Medtronic Holdings Ltd S-4 as filed 11-20-14
Shareholder FAQ - Updated 11-18-14
Medtronic and Covidien Record and SH Mtg Dates posted 11-17-2014
Medtronic 8k– Bank Financing Agreement Filed 11-10-2014
Medtronic – Covidien Investor Presentation Updated 10-3-2014
Medtronic & Covidien Transaction Information
Webcast of announcement
Medtronic Covidien Rule 2.5 filing
Covidien Rule 210 Announcement
Medtronic – Covidien: A Combination to Drive…
Medtronic SEC Filings Page

Required Medtronic – Covidien documents for inspection
A&L Goodbody Opinion (including A&L Goodbody consent) dated 20 November 2014
Amended and Restated Five-Year Senior Credit Agreement dated 23 May 2014
Amended and Restated Revolving Credit Agreement dated 7 November 2014
Charter Documents of Medtronic
Covidien's annual report on Form 10-k for the fiscal year ended 27 September 2013
Covidien's annual report on form 10-k for the fiscal year ended 28 September 2012
Covidien's annual report on Form 10-k for the fiscal year ended 30 September 2011
Covidien's current report on form 8-K dated 11 July 2014
Covidien's quarterly report on form 10-Q for the Quarterly Period Ended 28 March 2014
Covidien's quarterly report on form 10-Q in respect of Covidien's quarterly period ended 27 June 2014
Eighth Supplemental Indenture dated 16 May 2013
Employee Matters Agreement dated 28 June 2013
Covidien's quarterly report on form 10-Q in respect of Covidien's quarter ended 27 December 2013
Expenses Reimbursement Agreement dated 15 June 2014
Explanation for Optionholders and Equity Award Holders and Joint Letter to Equity Award Holders
Fifth Supplemental Indenture dated March 26 2013
Full list of the dealings of Goldman Sachs in Medtronic Inc securities
Letter of Consent from Deloitte & Touche
Letter of Consent from Goldman Sachs (No.1)
Letter of Consent from Goldman Sachs (No.2)
Letter of Consent from Perella Weinberg Partners
Letter of Consent from PwC
Medtronic - Form 10-K for fiscal year ended April 25, 2014
Medtronic - Form 10-K for fiscal year ended April 26, 2013
Medtronic - Form 10-K for fiscal year ended April 27, 2012
Medtronic - Form 10-Q for period year ended July 25, 2014
Memorandum and Articles of Association of Covidien
Reports pursuant to Rule 19.3(b)(ii) of the Irish Takeover Rules
Rule 28.3 Report by Perella Weinberg Partners on the Medtronic Profit Forecast (including Perella Weinberg Partners consent)
Rule 2.5 Announcement dated 15 June 2014
Rule 28.3 Report by Deloitte & Touche on the Covidien Profit Forecast
Rule 28.3 Report by Goldman Sachs on the Covidien Profit Forecast
Rule 28.3 Report by PwC on the Medtronic Profit Forecast
Senior Unsecured Bridge Agreement dated 7 November 2014
Senior Unsecured Term Loan Agreement dated 7 November 2014
Separation and Distribution Agreement dated 28 June 2013
Sixth Supplemental Indenture dated 27 February 2014
Tax Matters Agreement dated 28 June 2013
Terminated Bridge Credit Agreement dated 15 June 2014
Terminated Cash Bridge Credit Agreement dated 15 June 2014
Transaction Agreement dated 15 June 2014
Transition Services Agreement dated 28 June 2013
Underwriting Agreement dated 13 May 2013
Underwriting Agreement dated 19 March 2013
Underwriting Agreement dated 20 February 2014

Founded in 1949, Medtronic has grown to become the world's largest independent medical technology company. At the core of all we do is our Mission: to alleviate pain, restore health and extend life. It provides a clear path for all employees as we work together to take Medtronic to the next level.More >>

Upcoming EventsRead More
There are currently no events scheduled.
Recent News Read More
Sustainability Index Endorsements        Read More



NYSE (MDT)

Price$74.08
Change Stock is Up 0.31
Volume3,237,695
12/24/14
1:01 p.m. ET
Minimum 20 minute delay

Contact Us

Medtronic
Medtronic, Inc.
main number(763) 514-4000
Medtronic
Investor Relations
710 Medtronic Pkwy NE LC-480
Minneapolis, MN55432
work(763) 505-2692
Medtronic
Shareholder Services
work(763) 505-2510
workfax: (651) 367-0291

Latest Tweets

Medtronic News
@Medtronic

Latest Tweets

Omar Ishrak
@MedtronicCEO

United States